Your session is about to expire
← Back to Search
Neosporin for COVID-19
Study Summary
This trial will test if neosporin can help increase local immunity in the nose compared to a placebo control.
- COVID-19
- Coronavirus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You are allergic to aminoglycoside antibiotics such as neomycin, tobramycin, and gentamycin.You are currently experiencing symptoms related to your nose or breathing.You are not allowed to use any nasal medications, including over-the-counter products or nasal flush products.You have taken antibiotics by mouth or applied to your skin within the last 14 days.You are currently taking corticosteroids or medication that weakens your immune system.You are able and willing to follow the instructions for using a nasal medication.
- Group 1: Neosporin
- Group 2: Vaseline or equivalent
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Neosporin been formally authorized by the FDA?
"The safety profile of Neosporin has been assessed as a 1 on our organization's rating scale, due to its status as a Phase 1 trial. This suggests that there is only minimal evidence supporting the medication's efficacy and security."
Are individuals outside of the age range 65 and below being considered for this experiment?
"The accepted age range for this medical trial is 18 to 60. Participants aged below 18 and over 65 years old are instead directed towards 140 different studies or 911 separate clinical trials respectively."
How many individuals are involved in this trial's experimentation?
"Affirmative. According to clinicaltrials.gov, the recruitment for this medical study is open as of September 1st 2022 and was recently updated on 12th of same month. The trial requires 46 participants from a single site."
Is it feasible for me to participate in this medical research?
"This medical trial seeks 46 individuals suffering from covid-19 that are between 18 and 60 years old. The necessary criteria for enrollment includes: providing informed consent, being negative to the virus within 48 hours of joining based on PCR or antigen test (in case a participant tests positive, they will be given further instructions), demonstrating good general health in their history, having the ability to take nasal medication and abiding by its regimen."
Is this experiment currently recruiting participants?
"Affirmative, the information on clinicaltrials.gov demonstrates that this investigation is recruiting individuals at present. It was first posted on September 1st 2022 and has since been updated as of September 12th 2022. 46 participants are needed from a solitary medical centre for the trial to be successful."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger